English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Shenghua Biok: revenue of pesticides -34.2% in 2016qrcode

May. 12, 2017

Favorites Print
Forward
May. 12, 2017
 By Think Real – Chinese agrochemical company Zhejiang Shenghua Biok Biology Co., Ltd. (Shenghua Biok) announced that it made revenue of USD145.7 million and net profit of USD34.1 million in 2016, respectively down by 0.46% and up by 68.4% YoY.
 
The large rise in net profit can be mainly attributed to rises in profit made by the affiliated companies Caitong Fund Management Co., Ltd. and Qingdao Yebio Bio-engineering Co., Ltd., and the investment principle and interest collected from the equity investment.
 
Specifically, Shenghua Biok recorded a significant fall in the revenue from its pesticide business, by 34.2% YoY to USD20.6 million. Here are key reasons:
 
1. The sales of abamectin technical declined by about USD8.7 million.
 
2. Key dicamba competitors including Zhejiang Yangnong Chemical Group Co., Ltd. and Jiangsu Changqing Agrochemical Co., Ltd. put new production lines into operation, which was a big threat to its sales: sales price down by 23.8% YoY on average.
 
“Our plant is located in the Taihu basin, for which the production capacity expansion has been restricted by environmental policies in recent years,” stated Shenghua Biok, “Our market share of dicamba has decreased from 50%+ in 2013 to <10% currently, and the production capacity down from the 1st place to the 3rd place. Now our pricing and bargaining capabilities are weakened and great declines in profit and even deficits are seen.”
 
3. In 2015, Shenghua Biok transferred its shares in Ningxia Gerui Fine Chemicals Co., Ltd. (Ningxia Gerui) which is mainly producing PMIDA, an intermediate for glyphosate. Hence, Ningxia Gerui’s financial figures have been removed from Shenghua Biok’s consolidated financial report since 30 April, 2015.
 
In April 2016, Shenghua Biok released the Future Strategic Development Plan (2016-2020), stressing the focus on the “pan-entertainment (based on intellectual property)”. Currently, the proposal to purchase assets by issuing shares and paying in cash and to raise supporting funding is progressed.
 
Table: Revenue and gross margin of main business of Shenghua Biok, 2016
Item
Revenue,
million USD
YoY change
Gross margin
YoY change,
percentage points
By product
Pesiticdes
20.6
-34.2%
3.6%
-5.2
Zirconium-based
 products
32.7
9.8%
6.2%
-0.52
Veterinary drug
62.2
-4.4%
17.4%
-0.1
Chemicals
12.4
25.2%
8.3%
-1.4
Electricity
 and steam
7.8
12.9%
25.8%
-4.7
Others
6.5
300.8%
14.8%
-23.5
By region
Domestic
94.5
16.7%
10.8%
-1.6
Overseas
47.8
-25.0%
15.5%
0.2
Source: Shenghua Biok


 
Source: Think Real

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox